Half Year 2021 Hikma Pharmaceuticals PLC Earnings Call (Q&A Session) Transcript
Okay. It looks like we have everyone in the room, and we're ready to kick off.
Thanks, Layan. So we're ready to go. I thought we would just open it straight up for questions and answers. So if you have a question, let us know, and we'd be happy to kick it off.
Questions & Answers
So this is just going to be the usual setup. (Operator Instructions)
So we already have our first question from Pete Verdult.
Yes. Peter Verdult, Citi. Two questions. Just firstly, maybe just starting with Branded actually. Great start to the year. You're still saying mid-single-digit growth basically means that you're going to be declining in the second half. I know you talked about some pull-through, but can you just help us understand, is there any sort of upside risks growing Branded versus the guidance, not just near term,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |